GE HealthCare Prepares for Q2 2025 Earnings Release, Investor Focus on Growth Trajectory

CHICAGO – July 7, 2025 – GE HealthCare Technologies Inc. (Nasdaq: GEHC) today announced its schedule for the release of its second quarter 2025 financial results. The highly anticipated announcement will take place before the market opens on Wednesday, July 30, 2025. This release is a critical event for investors, analysts, and stakeholders, offering a comprehensive look into the company's financial performance and operational progress during the second quarter.

Following the earnings release, the GE HealthCare management team will host a conference call and live webcast at 8:30 a.m. Eastern Time (7:30 a.m. Central Time) on the same day. This interactive session provides an invaluable opportunity for the investment community to gain direct insights from the company's leadership. Management is expected to discuss key financial metrics, operational highlights, strategic initiatives, and provide updated guidance for the remainder of the fiscal year. The live webcast will be accessible to all interested parties via the company’s investor relations website at https://investor.gehealthcare.com/news-events/events. A replay of the webcast, along with the earnings release and accompanying financial information, will also be made available on the site shortly after the live event concludes.

Market Context and Investor Expectations

GE HealthCare, a global leader in medical technology, diagnostics, and digital solutions, has been under close scrutiny since its spin-off from General Electric. Investors are keenly focused on the company's ability to drive sustainable growth, particularly in its core segments such such as Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics. The second quarter results will be crucial in assessing the effectiveness of its strategic investments in innovation, market expansion, and digital transformation initiatives.

Analysts will be paying close attention to several key performance indicators (KPIs). Revenue growth, both organic and reported, will be a primary focus, especially in light of global healthcare spending trends and supply chain dynamics. Profitability metrics, including adjusted EBIT (Earnings Before Interest and Taxes) margin and free cash flow, will provide insights into the company's operational efficiency and capital allocation strategies. Furthermore, any updates on order growth, backlog, and regional performance will offer a deeper understanding of the company's market position and future revenue potential.

The healthcare technology sector continues to evolve rapidly, driven by advancements in artificial intelligence, precision medicine, and connected care. GE HealthCare's ability to capitalize on these trends through its product pipeline and digital offerings will be a significant determinant of its long-term success. The upcoming earnings call is an opportune moment for management to elaborate on these strategic priorities and demonstrate how they are translating into tangible financial results.

Investment Insights and Forward Look

For current and prospective investors, the Q2 2025 earnings call presents a critical juncture. Beyond the headline numbers, investors should listen for commentary on:

• Segment Performance: Detailed breakdown of revenue and profit contributions from each of GE HealthCare's key segments, identifying areas of strength and potential challenges.
• Innovation and R&D: Updates on new product launches, regulatory approvals, and the progress of its research and development pipeline, particularly in high-growth areas like AI-powered diagnostics and therapeutic solutions.
• Global Market Dynamics: Management's perspective on regional market conditions, competitive landscape, and the impact of macroeconomic factors on demand for healthcare equipment and services.
• Capital Allocation: Insights into the company's plans for capital expenditures, share buybacks, dividends, and potential M&A activities that could enhance its portfolio or market reach.
• Outlook and Guidance: Any revisions to full-year 2025 financial guidance will be closely scrutinized, providing a forward-looking perspective on the company's expected performance.

Investors should also consider the broader healthcare industry trends, including the increasing demand for personalized medicine, the shift towards value-based care, and the growing importance of digital health solutions. GE HealthCare's strategic alignment with these trends will be key to its continued market leadership. The upcoming earnings report and subsequent conference call will provide essential data points for investors to re-evaluate their positions and make informed decisions regarding GEHC stock.